| 제목 | Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors | ||
|---|---|---|---|
| 작성자 | 관리자 | 등록일 | 2022-07-13 |
내용
Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors
Danbee Kang 1 2, Youngha Kim 2, Jihyun Lim 2, Junghee Yoon 3, Sooyeon Kim 1 2, Eunjee Kang 2 4, Heesu Nam 1 2, Sungkeun Shim 2 3, Mangyeong Lee 2 3, Haesook Bok 5 6, Sang-Won Lee 6, Soo-Yong Shin 3 7, Jin Seok Ahn 8, Dongryul Oh 9, Juhee Cho 1 2 3 4
Affiliations expand
- PMID: 33848414
- PMCID: PMC8756127
- DOI: 10.4143/crt.2020.1200
Abstract
Purpose: The purpose of the study was to validate the Korean version of Patient-Reported Outcomes Measurement Information System 29 Profile v2.1 (K-PROMIS-29 V2.1) among cancer survivors.
Materials and methods: Participants were recruited from outpatient clinics of the Comprehensive Cancer Center at the Samsung Medical Center in Seoul, South Korea, from September to October 2018. Participants completed a survey questionnaire that included the K-PROMIS-29 V2.1 and the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30). Principal component analysis and confirmatory factor analysis (CFA) and Pearson's correlations were used to evaluate the reliability and validity of the K-PROMIS-29 V2.1.
Results: The mean age of the study participants was 54.4 years, the mean time since diagnosis was 1.2 (±2.4) years, and 349 (87.3%) completed the entire questionnaire. The Cronbach's alpha coefficients of the seven domains in the K-PROMIS-29 V2.1 ranged from 0.81 to 0.96, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the K-PROMIS-29 V2.1 were high (comparative fit index, 0.91 and standardized root-mean-squared residual, 0.06). High to moderate correlations were found between comparable subscales of the K-PROMIS-29 V2.1 and subscales of the EORTC QLQ-C30 (r=0.52-0.73).
Conclusion: The K-PROMIS-29 V2.1 is a reliable and valid measure for assessing the health-related quality of life domains in a cancer population, thus supporting their use in studies and oncology trials.
Keywords: Cancer; PROMIS-29; Quality of life; Validation.
